Itraconazole Neon Healthcare (Itraconazole)

Itraconazole blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for converting lanosterol to ergosterol. Without ergosterol, the fungal cell membrane becomes unstable, inhibiting growth and leading to cell death. This mechanism targets a broad range of pathogenic fungi.

The specific dose and infusion rate are determined by the treating physician based on the type and severity of the infection, patient weight, renal and hepatic function, and other clinical factors. Only a qualified healthcare professional should prescribe the exact regimen.

Itraconazole is classified as Pregnancy Category D, indicating evidence of risk to the fetus. It should be used during pregnancy only if the potential benefit justifies the risk. Breastfeeding is not recommended while receiving itraconazole because the drug may be excreted in milk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and required import documentation.

Compared with other azole antifungals, itraconazole offers a broad spectrum against many dimorphic fungi and has a relatively long half‑life, allowing once‑daily dosing for oral formulations. However, its intravenous form provides rapid serum concentrations useful for severe infections, whereas some alternatives like voriconazole may have different drug‑interaction profiles.

Store at ambient temperature: keep the vial in its original packaging, protect from direct light, and avoid exposure to moisture. Do not freeze the solution. Follow any additional handling instructions provided on the label.

The product is supplied as a sterile intravenous solution. It is infused through a dedicated IV line by a qualified healthcare professional, typically over a period of 30 minutes to several hours, depending on the prescribed dose and clinical protocol.

Serious risks include hepatotoxicity, severe allergic reactions such as anaphylaxis, cardiac arrhythmias, visual disturbances, and rare skin reactions like Stevens‑Johnson syndrome. Patients should be monitored closely for signs of liver injury, cardiac issues, and hypersensitivity throughout treatment.

Itraconazole is contraindicated in patients with known hypersensitivity to itraconazole or any azole antifungal, and in those with severe ventricular dysfunction. Caution is also advised for patients taking strong CYP3A4 inducers or inhibitors, and for individuals with significant liver impairment.